{
    "nctId": "NCT01856491",
    "officialTitle": "RELIANCE 4-FRONT\u2122 Passive Fixation Defibrillation Lead Post Market Clinical Follow-Up (PMCF) Study",
    "inclusionCriteria": "* Willing and capable of providing informed consent\n* Has an indication for implantation of a single or dual chamber ICD or CRT-D system in their respective geography\n* Subjects planned to be implanted with the RELIANCE 4-FRONT Passive Fixation Lead\n* Willing and capable of participating in all testing/ visits associated with this clinical study at an approved clinical study center and at the intervals defined by this protocol\n* Age 18 or above, or of legal age to give informed consent specific to state and national law\n* Must have minimum age of 18 Years",
    "exclusionCriteria": "* Known or suspected sensitivity to Dexamethasone Acetate (DXA)\n* Mechanical tricuspid heart valve\n* Subject is enrolled in any other concurrent study without prior written approval from Boston Scientific (BSC), with the exception of local mandatory governmental registries and observational studies/registries that are not in conflict and do not affect the following:\n* Schedule of procedures for the RELIANCE 4-Front Study (i.e. should not cause additional or missed visits);\n* RELIANCE 4-Front Study outcome (i.e. involve medications that could affect the heart rate of the subject);\n* Conduct of the RELIANCE 4-Front Study per Good Clinical Practice (GCP)/ International Organization for Standardization (ISO) 14155:2011/ 21 CFR 812/ local regulations\n* Currently on the active heart transplant list\n* Documented life expectancy of less than 12 months\n* Women of childbearing potential who are or might be pregnant at the time of study enrollment (method of assessment upon physician discretion)\n* Currently requiring chronic dialysis"
}